Periampullary Cancer Clinical Trial
Official title:
The Effect of Enhanced Recovery After Surgery (ERAS) on Pancreaticoduodenectomy in Patients With Hepatobiliary-Pancreas (HBP) Disease
Enhanced Recovery After Surgery (ERAS) is not a program that aims to reduce postoperative hospital stay, but the multimodal strategies that aim to attenuate the loss of, and improve the restoration of, functional capacity after surgery on evidence-based medicine. The benefits of ERAS are proven in many surgical procedures, such as upper gastrointestinal surgery and colorectal surgery. Investigators performed Randomized Controlled Trials to evaluate the non-inferiority of modified ERAS protocol for pancreaticoduodenectomy (PD) by introducing standardized pre- and post-operative treatment based on ERAS treatment guidelines (ERAS on PD, Research Institute Clinical Progress, 2014-0961; ClinicalTrials.gov, NCT02372331). As a result of the study, the ERAS protocol proved to be non-inferior to the existing pre- and post-operative treatment in terms of surgical complications, mortality, hospital stay, total hospital cost, and most nutritional indicators. However, the previous study did not include a few important intraoperative items such as epidural analgesia and fluid balance among the main items of the ERAS protocol. This trial aims to evaluate the clinical results by applying the complete ERAS protocol.
Status | Not yet recruiting |
Enrollment | 334 |
Est. completion date | December 31, 2025 |
Est. primary completion date | June 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Age: 18 to 80 years old - Performance: Eastern Cooperative Oncology Group (ECOG) 0-2 - Resectable or borderline resectable malignant tumor or borderline malignant tumor on the periampullary area - No distant metastases - Bone marrow function: White Blood Cell (WBC) at least 3,000/mm3 or Absolute Neutrophil Count (ANC) = 1,500/mm3, Platelet count at least 125,000/mm3 - Liver function: aspartate aminotransferase (AST) / alanine aminotransferase (ALT) less than 3 times the upper limit of normal - Renal function: Creatinine no greater than 1.5 times the upper limit of normal - Patients who consented and signed informed consent Exclusion Criteria: - Patients with distant metastases or patients with recurrent periampullary carcinoma - Patients with active or uncontrolled infection - Patients with severe psychiatric/neurological disorders - People who are addicted to alcohol or other drugs - Patients included in other clinical studies that may affect this study - Patients unable to follow the researcher's instructions - Pregnancy - Patients with uncontrolled heart disease - Patients with moderate or more comorbidities that are judged to have an impact on quality of life or nutritional status (liver cirrhosis, chronic renal failure, heart failure, etc.) - Patients who underwent major abdominal organ surgery other than scheduled pancreaticoduodenectomy. - Patients who require combined resection of other major abdominal organs in addition to scheduled pancreaticoduodenectomy - History of allergy to local anesthetics - Local infection at the treatment site - Patients with neurological or mental health conditions - A history of spinal surgery or compression fractures at abdominal level - Patients with coagulopathy (Platelet < 125,000/mm3 or International Normalized Ratio (INR) = 1.5) or who continue to take anticoagulants or antithrombotic drugs without stopping - Others who are not suitable for research in the judgment of the clinician |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine | Seoul |
Lead Sponsor | Collaborator |
---|---|
Asan Medical Center |
Korea, Republic of,
Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, Gan TJ, Kennedy RH, Ljungqvist O, Lobo DN, Miller T, Radtke FF, Ruiz Garces T, Schricker T, Scott MJ, Thacker JK, Ytrebo LM, Carli F. Enhanced Recovery After Surgery (ERAS) for gastrointestin — View Citation
Hwang DW, Kim HJ, Lee JH, Song KB, Kim MH, Lee SK, Choi KT, Jun IG, Bang JY, Kim SC. Effect of Enhanced Recovery After Surgery program on pancreaticoduodenectomy: a randomized controlled trial. J Hepatobiliary Pancreat Sci. 2019 Aug;26(8):360-369. doi: 10 — View Citation
Kim HE, Kim YH, Song KB, Chung YS, Hwang S, Lee YJ, Park KM, Kim SC. Impact of critical pathway implementation on hospital stay and costs in patients undergoing pancreaticoduodenectomy. Korean J Hepatobiliary Pancreat Surg. 2014 Feb;18(1):14-20. doi: 10.1 — View Citation
Kuemmerli C, Tschuor C, Kasai M, Alseidi AA, Balzano G, Bouwense S, Braga M, Coolsen M, Daniel SK, Dervenis C, Falconi M, Hwang DW, Kagedan DJ, Kim SC, Lavu H, Liang T, Nussbaum D, Partelli S, Passeri MJ, Pecorelli N, Pillai SA, Pillarisetty VG, Pucci MJ, — View Citation
Lee JH, Kim DH, Koh WU. Real-time ultrasound guided thoracic epidural catheterization: a technical review. Anesth Pain Med (Seoul). 2021 Oct;16(4):322-328. doi: 10.17085/apm.21060. Epub 2021 Oct 29. — View Citation
Melloul E, Lassen K, Roulin D, Grass F, Perinel J, Adham M, Wellge EB, Kunzler F, Besselink MG, Asbun H, Scott MJ, Dejong CHC, Vrochides D, Aloia T, Izbicki JR, Demartines N. Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery A — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional recovery date on postopreative 7th day | Pain control is possible only with oral or patch-type analgesics without intravenous analgesic administration
Able to walk freely Free eating is possible There should be no evidence of infection related to surgery No intravenous nutritional injection (total parenteral nutrition) being administered |
The investigators evaluate the five items to the participant starting on the 7th day after surgery. A date that satisfies all five items is defined as functional recovery date. | |
Secondary | Postoperative complication | All complications after surgery are included. Especially, delayed gastric emptying, postpancreatectomy hemorrhage, postoperative pancreatic fistula and chyle leak will be classified by the criteria of International Study Group on Pancreatic Surgery.
The severity of all complication will be divided depends on Clavien Dindo classification (Grade from I to V, higher scores mean a better outcome). |
Three months after surgery | |
Secondary | Postoperative mortality | All in-hospital mortality and 90 days mortality | 90 days after surgery | |
Secondary | Re-admission rate | For any reason, all readmitted patients are included. | 3 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04095312 -
Clinical Study for Evaluating the Clinical Safety and Effectiveness of the Automated Robotic Robot, Revo-i Surgical Robot System (Model MSR-5100), Used for General Endoscopic Surgery.
|
N/A | |
Recruiting |
NCT05155878 -
Prognostic Factors in Periampullary Tumors and Cysts
|
||
Recruiting |
NCT03724994 -
Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer
|
||
Recruiting |
NCT03063554 -
EUS BD vs ERCP TP for Pancreatic Cancer
|
N/A | |
Completed |
NCT03870698 -
Comparison of Functional Recovery Between Laparoscopic and Open Pancreaticoduodenectomy
|
N/A | |
Terminated |
NCT04311047 -
Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI
|
N/A | |
Not yet recruiting |
NCT06381882 -
The Role of the Human Microbiome in Patients After Pancreatic Resection.
|
||
Recruiting |
NCT03138213 -
Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy
|
N/A | |
Withdrawn |
NCT01913275 -
Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT04401722 -
Clinical Impact of Altitude Level on Surgical Outcomes of Pancreaticoduodenectomy
|
N/A | |
Not yet recruiting |
NCT05843877 -
Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula
|
Phase 3 | |
Completed |
NCT02787512 -
Preoperative Biliary Drainage With Metal Versus Plastic Stents in Periampullary Cancer
|
N/A | |
Completed |
NCT02900950 -
Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer
|
N/A | |
Recruiting |
NCT06069297 -
Prehabilitation in Pancreatic Surgery
|
N/A | |
Completed |
NCT01789502 -
Comparison Between Fully Covered Metal Stents and Plastic Stents in Preoperative Biliary Drainage
|
N/A | |
Suspended |
NCT04714983 -
DNX-2440 for Resectable Colorectal Liver Metastasis
|
Phase 1 | |
Terminated |
NCT05289830 -
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
|
Phase 2 | |
Completed |
NCT04289831 -
Preoperative Biliary Drainage in Patients With Operable Malignant Periampulary Tumors
|
N/A | |
Completed |
NCT00841607 -
Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy
|
N/A | |
Completed |
NCT04985071 -
Complication of Pancreatic Fistula and Bleeding After Pancreaticoduodenectomy in Treatment Periampullary Cancer
|